A study to test how BI 764532 is taken up by tumours in people with small-cell lung cancer or neuroendocrine cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501818-54-00

Acronym

1438-0004

Enrollment

Registered

2023-08-17

Start date

2024-02-22

Completion date

Unknown

Last updated

2024-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Large cells neuroendocrine lung carcinoma (LCNEC), "Neuroendocrine carcinoma (NEC) or small cell carcinoma of any other origin", Small cell lung carcinoma (SCLC)

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

Netherlands

Outcome results